Grifols, one of the world’s three top providers of plasma-derived medicines to treat life-threatening diseases, will officially present the Grifols Hemophilia Awareness Global Awards (GHAGA) at the 27th Congress of the International Society on Thrombosis and Haemostasis (ISTH), taking place July 6-10, 2019, in Melbourne, Australia.
The GHAGA aim to encourage health care providers, hemophilia treatment centers as well as hemophilia societies to submit proposals that would contribute to improving the care of hemophilia patients and their quality of life.
Grifols will award four 50,000 euro grants to eligible proposals and name the recipients in early 2020.
Participants from any country worldwide may submit a proposal that fulfills the program’s objectives:
- Improve education to patients, families, caregivers, healthcare providers or patients advocacy groups
- Support outreach by increasing disease awareness or access to diagnosis
- Strengthen diagnosis by helping to improve patients care and quality control in hemophilia treatment centers
- Facilitate access to treatment
The program is a tangible contribution to the improvement of standards and benefits for patient care in hemophilia where it is not available yet, such as in countries with limited economic resources.
There are approximately 400,000 people in developed and developing regions who have this inherited condition.
Applications will be accepted from July 6, 2019, until November 1, 2019.